Understanding immune system behaviour in blood cancers
Making a difference to the lives of her patients is why Dr Wei Jiang gets up each morning.
- Other blood cancers
- Research
Category: Research
New classifications of MPN mean better diagnostics and more definitive prognoses
How the MPNs are classified is set to change with eight new classifications based on the underlying mechanisms that drive the mutations.
- Myeloproliferative neoplasms
- Research
Preventing different forms of resistance to AML would “make a massive difference”
Leukaemia Foundation Research Fellowship recipient Mark Dawson discusses various areas of AML research.
- Acute myeloid leukaemia
- Research
About the Hovon 150 Trial
The aim of the HOVON 150 trial* is to recruit 968 patients from Europe, Australia and other participating countries.
- Acute myeloid leukaemia
- Research
- Treatments and side-effects
Quest to better understand MDS and find out more effective therapies
When someone with MDS is treated with azacitidine (Vidaza®), it takes six months to find out if they are responding to the drug. Dr Unnikrishnan is working to change that.
- Myelodysplastic syndromes
- Research
Talking lymphoma with Associate Professor Jake Shortt
Assoc. Prof. Shortt talks about his work in non-Hodgkin lymphoma research.
- Non-Hodgkin lymphoma
- Research
Developing new treatments for Burkitt’s lymphoma
Dr Gemma Kelly is investigating a new anti-cancer drug to treat Burkitt's lymphoma.
- Non-Hodgkin lymphoma
- Research
Searching for biomarkers and better treatments for B-cell lymphomas
Professor Ricky Johnstone hopes to find new research treatments for B-cell lymphomas.
- Acute myeloid leukaemia
- Myelodysplastic syndromes
- Myeloproliferative neoplasms
Saving lives from lymphoma
Dr Nath is hunting for more effective treatments.
- Research
Could the immune system hold the key to curing follicular lymphoma?
A world-first research group is investigating a new therapeutic approach.
- Non-Hodgkin lymphoma
- Research
